Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The effect of circuit resistance training, empagliflozin or "vegeterranean diet" on physical and metabolic function in older subjects with type 2 diabetes: a study protocol for a randomized control trial (CEV-65 trial).
Buch A, Eldor R, Kis O, Keinan-Boker L, Dunsky A, Rubin A, Lopez A, Sofer Y, Osher E, Marcus Y, Stern N. Buch A, et al. Among authors: Eldor R. BMC Geriatr. 2019 Aug 22;19(1):228. doi: 10.1186/s12877-019-1219-7. BMC Geriatr. 2019. PMID: 31438863 Free PMC article.
Exenatide modulates visual cortex responses.
Binda P, Eldor R, Huerta C, Adams J, Lancaster J, Fox P, Del Prato S, DeFronzo R, Abdul-Ghani M, Daniele G. Binda P, et al. Among authors: Eldor R. Version 2. Diabetes Metab Res Rev. 2019 Sep;35(6):e3167. doi: 10.1002/dmrr.3167. Epub 2019 May 6. Diabetes Metab Res Rev. 2019. PMID: 30974038 Free PMC article.
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial.
Home PD, Lam RLH, Carofano WL, Golm GT, Eldor R, Crutchlow MF, Marcos MC, Rosenstock J, Hollander PA, Gallwitz B. Home PD, et al. Among authors: Eldor R. Diabetes Obes Metab. 2018 Sep;20(9):2220-2228. doi: 10.1111/dom.13354. Epub 2018 Jun 5. Diabetes Obes Metab. 2018. PMID: 29766635 Clinical Trial.
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial.
Hollander PA, Carofano WL, Lam RLH, Golm GT, Eldor R, Crutchlow MF, Marcos MC, Rendell MS, Home PD, Gallwitz B, Rosenstock J. Hollander PA, et al. Among authors: Eldor R. Diabetes Obes Metab. 2018 Sep;20(9):2229-2237. doi: 10.1111/dom.13363. Epub 2018 Jun 10. Diabetes Obes Metab. 2018. PMID: 29761615 Clinical Trial.
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.
Pratley RE, Eldor R, Raji A, Golm G, Huyck SB, Qiu Y, Sunga S, Johnson J, Terra SG, Mancuso JP, Engel SS, Lauring B. Pratley RE, et al. Among authors: Eldor R. Diabetes Obes Metab. 2018 May;20(5):1111-1120. doi: 10.1111/dom.13194. Epub 2018 Jan 25. Diabetes Obes Metab. 2018. PMID: 29266675 Free PMC article. Clinical Trial.
Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1α promoter methylation in healthy subjects.
Eldor R, Norton L, Fourcaudot M, Galindo C, DeFronzo RA, Abdul-Ghani M. Eldor R, et al. PLoS One. 2017 Dec 20;12(12):e0188208. doi: 10.1371/journal.pone.0188208. eCollection 2017. PLoS One. 2017. PMID: 29261667 Free PMC article.
Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized study.
Dagogo-Jack S, Liu J, Eldor R, Amorin G, Johnson J, Hille D, Liao Y, Huyck S, Golm G, Terra SG, Mancuso JP, Engel SS, Lauring B. Dagogo-Jack S, et al. Among authors: Eldor R. Diabetes Obes Metab. 2018 Mar;20(3):530-540. doi: 10.1111/dom.13116. Epub 2017 Oct 23. Diabetes Obes Metab. 2018. PMID: 28921862 Free PMC article. Clinical Trial.
Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline.
Ben Assayag E, Eldor R, Korczyn AD, Kliper E, Shenhar-Tsarfaty S, Tene O, Molad J, Shapira I, Berliner S, Volfson V, Shopin L, Strauss Y, Hallevi H, Bornstein NM, Auriel E. Ben Assayag E, et al. Among authors: Eldor R. Stroke. 2017 Sep;48(9):2368-2374. doi: 10.1161/STROKEAHA.117.017709. Epub 2017 Aug 11. Stroke. 2017. PMID: 28801477
Sex difference in the risk for exercise-induced albuminuria correlates with hemoglobin A1C and abnormal exercise ECG test findings.
Brzezinski RY, Etz-Hadar I, Grupper A, Ehrenwald M, Shapira I, Zeltser D, Berliner S, Rogowski O, Eldor R, Shenhar-Tsarfaty S. Brzezinski RY, et al. Among authors: Eldor R. Cardiovasc Diabetol. 2017 Jun 23;16(1):79. doi: 10.1186/s12933-017-0560-4. Cardiovasc Diabetol. 2017. PMID: 28645281 Free PMC article.
44 results
Jump to page
Feedback